• AI
  • Molecular Imaging
  • CT
  • X-Ray
  • Ultrasound
  • MRI
  • Facility Management
  • Mammography

Immunomedics makes $10 million placement

Article

Monoclonal antibody imaging agent developer Immunomedics of MorrisPlains, NJ, announced last week that it has sold $10 million inconvertible preferred stock to international investors. The investorscan convert the stock into shares of common stock over

Monoclonal antibody imaging agent developer Immunomedics of Morris

Plains, NJ, announced last week that it has sold $10 million in

convertible preferred stock to international investors. The investors

can convert the stock into shares of common stock over the next

two years.

Recent Videos
2 KOLs are featured in this series.
2 KOLs are featured in this series.
Can 18F-Floutufolastat Bolster Detection of PCa Recurrence in Patients with Low PSA Levels After Radical Prostatectomy?
2 KOLs are featured in this series.
2 KOLs are featured in this series.
2 KOLs are featured in this series.
2 KOLs are featured in this series.
2 KOLs are featured in this series.
2 KOLs are featured in this series.
2 KOLs are featured in this series.
Related Content
© 2024 MJH Life Sciences

All rights reserved.